ESID Grand Rounds 10: Liver disease in CVID

(1:38:28)

ESID Grand Rounds February 2024: Immune Dysregulation

(1:48:41)

ESID Grand Round 7: HSCT for adults with IEI

(1:22:4)

ESID Grand Rounds 29: Monogenic atopic disorders

(1:35:8)

ESID Grand Rounds 28: Antimicrobial prophylaxis

(1:15:13)

ESID Grand Rounds 19: The Power of Flow-based assays in Diagnostics of IEI

(1:30:36)

ESID Grand Rounds 15: Vaccination and inborn errors of immunity: update on clinical guidelines

(1:34:18)

ESID Grand Round 1: Managing COVID in Adults with Antibody Deficiency

(1:15:51)

odyssey osce series - primary immunodeficiency

(1:1:51)

Inborn Errors of Immunity (Abraham)

(1:6:28)

5th Biennial Conference on Primary Immunodeficiency Diseases l Day 2 : 9:00 AM - 5:00PM

(8:48:21)

ESID JUNIORS JOURNAL CLUB APRIL 2022

(23:59)

¿Qué es Hotmart y Cómo Puedes Ganar Dinero Desde Casa con Este Modelo de Negocio Digital? 💻💰

(19:36)

CTLA-4 mediated regulation of autoimmunity by Dr. Lucy Walker

(44:21)

Introduction to Primary Immunodeficiency Diseases

(47:50)

C-Suite Fireside Executive Chat on ESG: A Boardroom Agenda

(1:10:2)

The Various Hyper IgE Syndromes (HIES)

(1:1:14)

Hospice | Part One

(7:55)

ESID Grand Rounds 17: Recent advances in HSCT for IEI– haploidentical transplantation

(1:18:54)

Ground Round March 2024: Systemic autoinflammatory disease

(1:21:23)

ESID Grand Rounds 21: Gastrointestinal complications in CVID from pathology to management

(1:36:3)

ESID Grand Rounds 20: Management of CGD in the 21st Century

(1:29:6)

ESID Grand Round 22: Transitional Guidelines

(1:47:31)

ESID Grand Round 6: Interstitial Lung Disease (ILD) in Common Variable Immunodeficiency (CVID)

(1:41:34)

ESID Grand Rounds 16: Where is gene therapy for PID?

(1:33:31)

ESID Grand Rounds 18: Challenges of interpreting genetic reports for clinicians

(1:29:24)

ESID Grand Rounds 9: STOP XLA

(1:2:33)

ESID Grand Rounds 14: Contemporary Management of DN-STAT3 / Job’s syndrome

(1:28:12)

ESID Grand Rounds 12: JAKinh in IEIs of the JAK/STAT pathway

(1:38:48)